DEFINITION

Severe deficit

  • Serum Mg2+ <0.5 mmol/L

Moderate deficit

  • Serum Mg2+0.5–0.7 mmol/L

Mild deficit

  • Magnesium is largely intracellular so mild deficiency can occur with a normal serum concentration, but urine excretion will be reduced:
    • urine Mg2+/urine creatinine <0.1 = deficiency; <0.05 = severe deficiency, except if secondary to renal loss – see Investigations

COMMON CAUSES

Gastrointestinal loss

  • Diarrhoea
  • Stoma
  • Fistula
  • Malabsorption states
  • Proton pump inhibitors (PPIs)

Renal loss

  • Tubular damage
  • Genetic syndromes (e.g. Gitelman’s syndrome)
  • Chronic acidosis
  • Phosphate or potassium depletion
  • Hypoparathyroidism
  • Drug-induced (e.g. loop and thiazide diuretics, aminoglycosides, ciclosporin, cisplatin)

Other

  • Alcoholism
  • Insulin administration
  • Critical illness

SYMPTOMS AND SIGNS

  • Non-specific and often attributed to hypocalcaemia or hypokalaemia

Musculoskeletal

  • Muscle twitching
  • Tremor
  • Tetany
  • Cramps

CNS

  • Apathy
  • Depression
  • Hallucinations
  • Agitation
  • Confusion
  • Fits

Cardiovascular

  • Tachycardia
  • Hypertension
  • Arrhythmias (e.g. torsade de pointes)
  • Digoxin toxicity

INVESTIGATIONS

  • Cause usually apparent from clinical picture – investigation necessary only if not obvious
  • Check U&E, bone profile and PTH as Mg2+ deficiency associated with hypocalcaemia and hypokalaemia
    • Calculate fractional excretion of Mg2+ in a random urine sample from:
Urine Mg2+x serum creatinine x 100
Serum Mg2+ x urine creatinine x 0.7

(units for each of urine and serum must be the same)

    • fractional excretion of Mg2+ >3% indicates renal loss. See above for causes
  • If hypocalcaemia or hyperphosphataemia present, check plasma parathyroid hormone

IMMEDIATE TREATMENT

Severe deficiency(Serum Mg2+ <0.5 mmol/L), intractable loss or symptoms of hypocalcaemia or hypokalaemia

  • IV route: Magnesium sulphate 5 g (20 mmol in 10 mL) into 250 mL glucose 5% (or sodium chloride 0.9%) over 4 hr
    • if given peripherally, monitor insertion site closely for phlebitis using a recognised infusion phlebitis scoring tool. Minimum dilution is 100 mL but more concentrated infusions should ideally be given centrally

Life-threatening features

  • Cardiac monitoring with resuscitation facilities available
  • Give a bolus of 2–4 g over 20 min

Moderate deficiency (serum Mg2+ >0.5 mmol/L)

  • Oral magnesium aspartate 243 mg powder for oral solution. Dose: 1–2 sachets (equivalent to 243–486 mg magnesium or 10–20 mmol magnesium) dissolved in 50–200 mL water, tea or orange juice, daily
    • if tolerance to oral intake limited by diarrhoea, reduce dose to maximum tolerated
  • Stop PPIs if possible, substituting H2 antagonists if necessary

MONITORING

  • Leave at least 2 hr after end of infusion before checking serum Mg2+
    • if still <0.5 mmol/L, repeat dose
    • otherwise, check again after 24 hr
  • Toxicity rare if renal function normal
  • Clinical signs of overdose:
    • loss of tendon reflexes (>5 mmol/L)
    • hypotension
    • bradycardia
    • respiratory depression (>7.5 mmol/L)